Prediction prognosis primary breast cancer detection high molecular mucin-like antigen monoclonal antibodies Cancer Leukemia Group study Three monoclonal antibodies MAbs expression distinct epitopes present family mucin-like carcinoma-associated molecules Primary tumor specimens stage II breast cancer patients expression high molecular weight antigens median follow-up years patients tumors high immunoperoxidase scores positive cells MAb superior disease-free survival DFS years overall survival OS years scores antibodies improved prognosis MAbs patients tumors apical cellular reactivity patterns DFS differences conventional levels statistical significance MAb multivariate analyses prognostic value MAb staining independent identified prognostic factors concordance primary axillary lymph node metastases MAb MAbs results MAb group node-positive women favorable prognosis Expression mucin-like glycoprotein differentiation MAb accurate objective estimate clinical outcome independent histopathologic evaluation 